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Cytosolic phospholipase A2 alpha (cPLA2a) is a calcium-dependent enzyme con-
stitutively expressed by most human cells catalyzing the hydrolysis of membrane 
glycerophospholipids bearing arachidonic acid at the sn-2 position with produc-
tion of downstream pro-inflammatory lipid mediators (Murakami and Kudo, 2002). 
Although cPLA2a seems to facilitate the release of pro-calcific matrix vesicles by 
hypertrophic chondrocytes during ossification (Wuthier et al., 1977), its involvement 
in pathological biomineralization has not yet been elucidated. Here, cPLA2a expres-
sion was assessed in the context of both pathological and experimentally induced 
mineralization affecting cardiovascular tissues and cultured aortic valve interstitial 
cells (AVICs). cPLA2a resulted to be expressed by fibroblasts, smooth muscle cells, 
macrophages, and activated endothelium populating both calcified aortic valves 
and atherosclerotic aorta walls. cPLA2a was also expressed by cultured AVICs, with 
enzyme expression rate correlating with mineralization rate, being enhanced by 
inflammation and high phosphate concentrations. For all calcific contexts, ultrastruc-
tural examination revealed mineralization to depend on progressive accumulation 
and release of acidic lipids, acting as major hydroxyapatite nucleators, followed by 
cell disgregation into a multitude of particles having calcium nucleation capability, 
according to peculiar degenerative patterns as those previously described (Ortolani et 
al., 2010).
In conclusion, enzyme expression and ultrastructural patterns being shared by 
both pathological and experimental calcific conditions suggests that cPLA2a might 
be actually involved in the etiopathogenesis of cardiovascular mineralization, besides 
representing a potential target for novel therapeutic strategies aimed to counteract 
the progression of cardiovascular calcific diseases.
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